市場調查報告書
商品編碼
1126547
自動周邊市場規模、份額、行業趨勢分析報告:按最終用途、類型、應用(青光眼、年齡相關性黃斑變性、暗點)、區域展望和預測2022-2028Global Automated Visual Field Analyzer Market Size, Share & Industry Trends Analysis Report By End-use, By Type, By Application (Glaucoma, Age-related Macular Degeneration, Scotoma), By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,全球自動周界市場規模預計將達到 2.278 億美元,在預測期內以 7.0% 的複合年增長率增長。
指示患者在周邊視覺中找到由周邊提供的特定光刺激。不這樣做可能會導致暗點或創傷。周邊投射一系列不同強度(亮度)的白光刺激,穿過一個均勻照明的碗。患者看到光線時通過按下手持設備上的按鈕發出信號。這評估了視網膜在視野內特定位置定位刺激的能力。
這以“分貝”為單位測量,稱為視網膜敏感度 (dB)。分析儀目前採用的 SITA(瑞典交互式閾值算法)可實現有史以來最快速和準確的視野評估。將結果與年齡匹配的數據庫進行比較可以揭示可能是病理性的可疑或意外視力喪失。該設備可用於疾病篩查、監測和診斷支持。可以根據目的選擇各種研究方法。
COVID-19 影響分析
由於醫院的選擇性程序(包括眼科檢查)延遲、感染風險以及就診眼科診所的人數等因素,COVID-19 對自動眼科設備市場產生了負面影響。正在減少。限制該行業的其他挑戰包括價格壓力、眼科醫生短缺、競爭加劇和高成本。此外,還有臨床意義,例如減少預約、避免某些療法、使用更多設備和新的程序實踐。正在鼓勵人工智能和遠程眼科加強醫患聯繫。
市場增長因素
快速的技術進步和分析儀技術的發展
在現代,自動化現場分析儀引入了許多進步。引入了一種新的軟件算法,這是該儀器複雜技術的重要進步之一。產品發布頻率的激增是預計推動市場擴張的主要因素之一。最近的技術發展導致了各種新的視覺功能測試的發展。
為醫生和患者提供更快的周轉時間
自動周界的周轉時間大大縮短,視野測試的準確性與近年來相比有所提高。由於在自動周邊市場上運營的幾家市場參與者做出了許多努力和努力,這些分析儀的周轉時間已大大縮短。更短的周轉時間使一些診所的醫生能夠加快患者診斷和治療的步伐。
市場增長因素
分析儀缺乏精度和多功能性
雖然自動邊界有很多優點,但它們也有很大的缺點。由於各種因素,自動周界容易出錯。例如,使用自動周邊完成的測試結果很容易受到不正確的頭部定位的干擾。即使患者頭部的輕微移動也會對測試結果產生很大影響。此外,患有嚴重青光眼的患者很難做出準確的診斷。
按類型劃分的前景
自動外圍市場按類型分為靜態和動態兩種。 2021 年,Kinetic 部門將在自動周邊市場獲得可觀的收入份額。動力學邊界的主要優點之一是它們能夠捕捉移動刺激並產生準確的結果。它的主要優點包括增加了檢查者和患者的互動、更快的外圍檢查和更好的空間分辨率。
應用前景
根據應用,自動周邊市場細分為青光眼、年齡相關性黃斑變性 (AMD)、暗點等。 2021 年,青光眼細分市場在自動周邊市場的收入份額最高。青光眼會損害眼睛的視神經,導致視力下降和失明。青光眼是由眼球內正常液體的壓力穩定增加引起的。
最終用戶展望
按最終用戶劃分,自動周邊市場分為醫院、眼科診所等。 2021年,醫院板塊在自動周邊市場的收入份額最大。該行業受到眼部相關疾病日益流行和自動化周邊技術發展的推動。
區域展望
按地區分析了北美、歐洲、亞太地區和 LAMEA 的自動周邊市場。 2021 年,北美佔自動周邊市場的最大收入份額。這是由於該地區有大量的市場參與者和眼疾患病率上升。自動周邊市場是由尖端技術的高度採用和有利的報銷政策推動的。
The Global Automated Visual Field Analyzer Market size is expected to reach $227.8 Million by 2028, rising at a market growth of 7.0% CAGR during the forecast period.
An automated visual field analyzer is an automated tool that is very frequently employed by Optometrists, orthoptists, and ophthalmologists to measure the human visual field, especially to identify monocular visual fields. The sort of vision defect is determined by the analyzer's results. As a result, it offers details on where any disease activates or lesion may be located along the visual pathway.
It directs and aids in the diagnosis of the visual disorder affecting the patient. These results are kept on file and utilized to keep tabs on the patient's health and the progression of vision loss. These analyzers examine the patient's whole vertical and horizontal field of peripheral vision, looking for any probable vision problems or blind spots (scotomas). Finding particular scotomas in one's vision can be a sign of a particular kind of brain injury or illness, like a tumor or stroke.
The patient is instructed to locate specific light stimuli that the analyzer has provided in their peripheral vision. If the patient is not able to do so, this may indicate scotomas or trauma. The analyzer emits a sequence of white light stimuli across a bowl that is evenly lit, with different intensities (brightness). The patient presses a button on a handheld device to signal when they see a light. This evaluates the retina's capacity to find a stimulus at particular locations within the visual field.
This is measured in 'decibels' and is known as retinal sensitivity (dB). The Swedish Interactive Thresholding Algorithm, or SITA, which is now used by the analyzer, enables the quickest and most precise visual field assessment to date. The results are then compared to an age-matched database to reveal suspicious and unexpected vision loss that may be a result of pathology. The analyzer can be employed for condition screening, monitoring, and diagnosis support. Depending on the objectives, there are a variety of testing methodologies to choose from.
COVID-19 Impact Analysis
COVID-19 had a negative impact on the automated visual field analyzers market because of elements, like the delay of elective hospital procedures, including eye exams, and the infection risk, which has led to a decline in the number of individuals attending eye clinics. Other challenges that are limiting the industry include a shortage of price pressure, ophthalmologists, escalating competition, and high costs. Additionally, it has had a clinical impact on fewer appointments, avoiding particular treatment alternatives, using more instruments, and putting new procedures into practice. Artificial intelligence and teleophthalmology are recommended for enhancing doctor-patient connections.
Market Growth Factors
Rapid Technological Advancement And Developments In The Analyzer Technology
In the modern era, there is a number of advancements that are being introduced in automated field analyzers. New software algorithms have been introduced, which is one of these significant advancements in the complex technology of this equipment. A surge in the frequency of product launches is one of the main factors projected to fuel the market's expansion. Recent developments in the technology are leading to the development of various novel visual function tests.
Offers Reduced Turnaround Time To Doctors And Patients
The turnaround time for automated visual field analyzers has greatly decreased, and accuracy in visual field testing has increased in contrast to recent years. Due to a number of efforts and initiatives being taken by several market players operating in the automated visual field analyzer market, the turnaround time of these analyzers has been reduced significantly. With the lesser turnaround time, doctors at several clinics are now able to accelerate the pace of diagnosis and treatment of their patients.
Market Growth Factors
Lack Of Precision And Versatility Of Analyzers
Despite a number of benefits of an automated visual field analyzer, there is a major drawback of this technology. Automated visual field analyzers are highly prone to making errors due to a number of factors. For example, the result of a test conducted with the automated field tester can be very easily hampered by incorrect placement of the head. Even a slight movement in the position of the patient's head can completely influence the result. Moreover, patients with severe glaucoma are very hard to be diagnosed accurately.
Type Outlook
On the basis of type, the Automated Visual Field Analyzer Market is bifurcated into Static and Kinetic. In 2021, the kinetic segment garnered a significant revenue share of the automated visual field analyzer market. The ability of kinetic visual field analyzers to capture moving stimuli and deliver precise results is one of its main advantages. Their main advantages include increased interaction between both the examiner and the patient, faster peripheral testing, and better spatial resolution.
Application Outlook
Based on Application, the Automated Visual Field Analyzer Market is segregated into Glaucoma, Age-related Macular Degeneration (AMD), Scotoma, and Others. In 2021, the glaucoma segment procured the highest revenue share of the automated visual field analyzer market. The optic nerve of the eye is damaged by glaucoma, which results in vision loss and blindness. Glaucoma is brought on by the usual fluid pressure in the eyes steadily raising.
End-User Outlook
By End-user, the Automated Visual Field Analyzer Market is segmented into Hospitals, Eye Clinics, and Others. In 2021, the hospitals segment witnessed the largest revenue share of the automated visual field analyzer market. The industry is being driven by both the increased prevalence of eye-related diseases and technological developments in automated visual field analyzers.
Regional Outlook
Region-Wise, the Automated Visual Field Analyzer Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America held the biggest revenue share of the automated visual field analyzer market. This can be ascribed to the region's large number of market players and rise in ocular illness prevalence. The market for automated visual field analyzers is being driven by the high adoption of cutting-edge technology and benevolent reimbursement policies.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Carl Zeiss AG, Metall Zug AG, Oculus Optikgerate GmbH, Kowa Company, Ltd., Heidelberg Engineering, Inc., Metrovision SAS, Optopol Technology Sp. z o.o., and MEDA Co., Ltd.
Strategies deployed in Automated Visual Field Analyzer Market
Partnerships, Collaborations and Agreements:
Dec-2019: Topcon partnered with Eastern Ophthalmic and Gold Coast Ophthalmic, two full-line authorized distributors. Under this partnership, Eastern Ophthalmic and Gold Coast Ophthalmic would commercialize Topcon's complete product portfolio, spanning from Topcon's industry-first fully automated OCT/fundus camera to its advanced digital and conventional refraction products and new data management software.
Product Launches and Product Expansions:
Apr-2022: Haag-Streit released the Eyestar 900, an Anterior Chamber Suit. Following this launch, the company aimed to fulfill the rising demand for enhanced results in refractive and cataract surgery. Moreover, the new swept-source OCT-based Eyestar 900 offers versatile tools for refractive and cataract surgery.
Aug-2019: Topcon unveiled the Maestro2, an automated OCT/Fundus camera. The new fully automated OCT Maestro2 can capture non-mydriatic high-resolution, true color fundus photography, OCTA, and OCT with a single click through its 360° rotating intuitive touchscreen and a space-saving design. Moreover, the new product also provides the Hood Report for the function/structure analysis of glaucoma.
Mar-2019: Zeiss introduced a new software upgrade to its Humphrey Field Analyzer. This product expansion aimed to establish 24-2C, a new testing protocol in response to the shift in customers' preference for testing and detection of macular injury within all stages of glaucoma. Moreover, the new software would also streamline and expedite visual field testing.
Dec-2018: Oculus rolled out the Smartfield perimeter. Through this launch, the company aimed to expand its compact visual field testing devices portfolio. The new device is specially optimized for central visual field functional impairment examinations. Furthermore, the new product also leverages an ultra-high luminance LCD display and its lower measurement durations make it compatible with standard screening methods.
Acquisitions and Mergers:
Jul-2020: Topcon Healthcare took over Elektron Eye Technology's Henson range of perimetry products. With this acquisition, the company aimed to leverage the prospect to strategically develop this sector of the product portfolio of the company. In addition, this Henson's product line would also complement the global strategy with the growing emphasis of Topcon on early disease detection and screening.
Market Segments covered in the Report:
By End-use
By Type
By Application
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures